相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pulmonary veno-occlusive disease: a probably underdiagnosed cause of pulmonary hypertension in systemic sclerosis
Ana Catarina Duarte et al.
CLINICAL RHEUMATOLOGY (2020)
Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects
Andreea M. Bujor et al.
FRONTIERS IN IMMUNOLOGY (2020)
Association of functional (GA)n microsatellite polymorphism in the FLI1 gene with susceptibility to human systemic sclerosis
Keita Yamashita et al.
RHEUMATOLOGY (2020)
The microbiome in autoimmune diseases
F. De Luca et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
A potential contribution of decreased galectin-7 expression in stratified epithelia to the development of cutaneous and oesophageal manifestations in systemic sclerosis
Ryosuke Saigusa et al.
EXPERIMENTAL DERMATOLOGY (2019)
Autoantibodies are present before the clinical diagnosis of systemic sclerosis
Peter D. Burbelo et al.
PLOS ONE (2019)
Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti-topoisomerase I-positive systemic sclerosis-associated interstitial lung disease
Satoshi Ebata et al.
JOURNAL OF DERMATOLOGY (2019)
Dermal adipose tissue has high plasticity and undergoes reversible dedifferentiation in mice
Zhuzhen Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skin
Michael E. Johnson et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Nodular Regenerative Hyperplasia of the Liver: A Rare Vascular Complication in Systemic Sclerosis
Laura Graf et al.
JOURNAL OF RHEUMATOLOGY (2018)
A potential contribution of psoriasin to vascular and epithelial abnormalities and inflammation in systemic sclerosis
T. Takahashi et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis
Takashi Taniguchi et al.
EXPERIMENTAL DERMATOLOGY (2018)
Fibroblast heterogeneity: implications for human disease
Magnus D. Lynch et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
The human skin microbiome
Allyson L. Byrd et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8
Marie Dominique Ah Kioon et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Update on the Gastrointestinal Microbiome in Systemic Sclerosis
Chiara Bellocchi et al.
CURRENT RHEUMATOLOGY REPORTS (2018)
An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis
Takashi Yamashita et al.
SCIENTIFIC REPORTS (2018)
Regulatory T Cells in Systemic Sclerosis
Camelia Frantz et al.
FRONTIERS IN IMMUNOLOGY (2018)
pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosis
Suzanne Kafaja et al.
JCI INSIGHT (2018)
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression
Silvia Bosello et al.
ARTHRITIS RESEARCH & THERAPY (2018)
The role of gut microbiota in the pathogenesis of rheumatic diseases
Danli Zhong et al.
CLINICAL RHEUMATOLOGY (2018)
The impact of transcription factor Fli1 deficiency on the regulation of angiogenesis
Tetsuo Toyama et al.
EXPERIMENTAL DERMATOLOGY (2017)
Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma
Takehiro Takahashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Systemic Sclerosis Dermal Fibroblasts Suppress Th1 Cytokine Production via Galectin-9 Overproduction due to Fli1 Deficiency
Ryosuke Saigusa et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Dermal white adipose tissue implicated in SSc pathogenesis
John Varga et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta
Sara S. McCoy et al.
RHEUMATOLOGY (2017)
A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease
Dimitrios Daoussis et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target
Roberta G. Marangoni et al.
SCIENTIFIC REPORTS (2017)
Intestinal microbiome in scleroderma: recent progress
Elizabeth R. Volkmann
CURRENT OPINION IN RHEUMATOLOGY (2017)
Mapping and predicting mortality from systemic sclerosis
Muriel Elhai et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis
Mirko Manetti et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions
R. Saigusa et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
An overview of environmental risk factors in systemic sclerosis
Massimo De Martinis et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2016)
Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease
Fabian A. Mendoza et al.
ARTHRITIS & RHEUMATOLOGY (2016)
A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis
T. Takahashi et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Gastroesophageal reflux disease-related and functional heartburn: pathophysiology and treatment
Hiroto Miwa et al.
CURRENT OPINION IN GASTROENTEROLOGY (2016)
A clinical update on the significance of the gut microbiota in systemic autoimmunity
Elizabeth C. Rosser et al.
JOURNAL OF AUTOIMMUNITY (2016)
B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets
Ayumi Yoshizaki
JOURNAL OF DERMATOLOGY (2016)
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
Dinesh Khanna et al.
LANCET (2016)
Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
Sergio A. Jimenez et al.
MATRIX BIOLOGY (2016)
Current management of the gastrointestinal complications of systemic sclerosis
Anton Emmanuel
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Scleroderma renal crisis and renal involvement in systemic sclerosis
Thasia G. Woodworth et al.
NATURE REVIEWS NEPHROLOGY (2016)
Identification of an Association of TNFAIP3 Polymorphisms With Matrix Metalloproteinase Expression in Fibroblasts in an Integrative Study of Systemic Sclerosis-Associated Genetic and Environmental Factors
Peng Wei et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study
Veronika K. Jaeger et al.
PLOS ONE (2016)
A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis
T. Takahashi et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis
Yan Zhou et al.
HUMAN IMMUNOLOGY (2015)
Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis
Katherine G. MacDonald et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Serum omentin levels: A possible contribution to vascular involvement in patients with systemic sclerosis
Shunsuke Miura et al.
JOURNAL OF DERMATOLOGY (2015)
Serum vaspin levels: A possible correlation with digital ulcers in patients with systemic sclerosis
Shunsuke Miura et al.
JOURNAL OF DERMATOLOGY (2015)
Partially Evoked Epithelial-Mesenchymal Transition (EMT) Is Associated with Increased TGFβ Signaling within Lesional Scleroderma Skin
Joanna Nikitorowicz-Buniak et al.
PLOS ONE (2015)
Changes in forced vital capacity over time in systemic sclerosis: application of group-based trajectory modelling
Ada Man et al.
RHEUMATOLOGY (2015)
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis
Silvia L. Bosello et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Epigenetics and systemic sclerosis
Nezam Altorok et al.
SEMINARS IN IMMUNOPATHOLOGY (2015)
Fibrosis, Vascular Activation, and Immune Abnormalities Resembling Systemic Sclerosis in Bleomycin-Treated Fli-1-Haploinsufficient Mice
Takashi Taniguchi et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Progranulin Overproduction Due to Fli-1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis
Yohei Ichimura et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Myofibroblasts in Murine Cutaneous Fibrosis Originate From Adiponectin-Positive Intradermal Progenitors
Roberta Goncalves Marangoni et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Cardiomyopathy in Murine Models of Systemic Sclerosis
Paulius Venalis et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Systemic sclerosis
Yannick Allanore et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre
Gemma Lepri et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
Suzana Jordan et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis
Kaname Akamata et al.
RHEUMATOLOGY (2015)
Pulmonary veno-occlusive disease: a rare cause of pulmonary hypertension in systemic sclerosis. Case presentation and review of the literature
Ana Maria Daraban et al.
ROMANIAN JOURNAL OF INTERNAL MEDICINE (2015)
Vascular Receptor Autoantibodies in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis
Mike O. Becker et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Predictors of Mortality and Progression in Scleroderma-Associated Interstitial Lung Disease A Systematic Review
Tiffany A. Winstone et al.
CHEST (2014)
Rituximab for refractory digital infarcts and ulcers in systemic sclerosis
Chiew-Gek Khor et al.
CLINICAL RHEUMATOLOGY (2014)
Association between IRF5 polymorphisms and autoimmune diseases: a meta-analysis
L. Tang et al.
GENETICS AND MOLECULAR RESEARCH (2014)
Abnormally Differentiating Keratinocytes in the Epidermis of Systemic Sclerosis Patients Show Enhanced Secretion of CCN2 and S100A9
Joanna Nikitorowicz-Buniak et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis
Sayako Imura-Kumada et al.
Modern Rheumatology (2014)
Clinical significance of monitoring serum adiponectin levels during intravenous pulse cyclophosphamide therapy in interstitial lung disease associated with systemic sclerosis
Yuri Masui et al.
Modern Rheumatology (2014)
The role of genetics and epigenetics in the pathogenesis of systemic sclerosis
Jasper C. A. Broen et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Kidney involvement in systemic sclerosis
Virginia D. Steen
PRESSE MEDICALE (2014)
Serum resistin levels: a possible correlation with pulmonary vascular involvement in patients with systemic sclerosis
Yuri Masui et al.
RHEUMATOLOGY INTERNATIONAL (2014)
Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-Results from the International Scleroderma Renal Crisis Survey
Marie Hudson et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients
Jeannine Guenther et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction
Xiaoqin Yang et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis
Angela Kill et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Impaired In Vivo Neovascularization Capacity of Endothelial Progenitor Cells in Patients With Systemic Sclerosis
Masataka Kuwana et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Prediction of Pulmonary Complications and Long-Term Survival in Systemic Sclerosis
Svetlana I. Nihtyanova et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Serum apelin levels: clinical association with vascular involvements in patients with systemic sclerosis
N. Aozasa et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Clinical significance of serum retinol binding protein-4 levels in patients with systemic sclerosis
T. Toyama et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Dermal mast cell density in fingers reflects severity of skin sclerosis in systemic sclerosis
Sonosuke Yukawa et al.
MODERN RHEUMATOLOGY (2013)
A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune response
Yuri Masui et al.
RHEUMATOLOGY (2013)
IRF5 polymorphism predicts prognosis in patients with systemic sclerosis
Roozbeh Sharif et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
A Clinical and Serologic Comparison of African American and Caucasian Patients With Systemic Sclerosis
Virginia Steen et al.
ARTHRITIS AND RHEUMATISM (2012)
Adiponectin relation to skin changes and dyslipidemia in systemic sclerosis
Michal Tomcik et al.
CYTOKINE (2012)
Impaired IL-17 Signaling Pathway Contributes to the Increased Collagen Expression in Scleroderma Fibroblasts
Taiji Nakashima et al.
JOURNAL OF IMMUNOLOGY (2012)
Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis
Y. Masui et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
Swati Bhattacharyya et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Treatment of Systemic Sclerosis-Associated Calcinosis: A Case Report of Rituximab-Induced Regression of CREST-Related Calcinosis and Review of the Literature
Dimitrios Daoussis et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2012)
Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis
Russell Steele et al.
ARTHRITIS CARE & RESEARCH (2012)
Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker?
Katja Lakota et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22
Daniel S. Smyk et al.
AUTOIMMUNITY HIGHLIGHTS (2012)
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group
J. Avouac et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Involvement of functional autoantibodies against vascular receptors in systemic sclerosis
Gabriela Riemekasten et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Mast Cells Are a Source of Transforming Growth Factor β in Systemic Sclerosis
Thomas Huegle et al.
ARTHRITIS AND RHEUMATISM (2011)
Scleroderma Renal Crisis: A Rare but Severe Complication of Systemic Sclerosis
Luc Mouthon et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2011)
Systemic sclerosis and the heart: current diagnosis and management
Chintan S. Desai et al.
CURRENT OPINION IN RHEUMATOLOGY (2011)
Esophageal dysmotility associated with systemic sclerosis: a high-resolution manometry study
S. Roman et al.
DISEASES OF THE ESOPHAGUS (2011)
Adiponectin expression is decreased in the involved skin and sera of diffuse cutaneous scleroderma patients
Hiroki Arakawa et al.
EXPERIMENTAL DERMATOLOGY (2011)
Liver pathology in collagen vascular disorders highlighting the vascular changes within portal tracts
Kim Vaiphei et al.
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY (2011)
The skin microbiome
Elizabeth A. Grice et al.
NATURE REVIEWS MICROBIOLOGY (2011)
Nodular regenerative hyperplasia: Evolving concepts on underdiagnosed cause of portal hypertension
Marek Hartleb et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Genome-Wide Scan Identifies TNIP1, PSORS1C1, and RHOB As Novel Risk Loci for Systemic Sclerosis
Yannick Allanore et al.
PLOS GENETICS (2011)
Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide
Elena Tourkina et al.
FIBROGENESIS & TISSUE REPAIR (2011)
Primary Biliary Cirrhosis Associated with Systemic Sclerosis: Diagnostic and Clinical Challenges
Cristina Rigamonti et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2011)
Endothelial Fli1 Deficiency Impairs Vascular Homeostasis A Role in Scleroderma Vasculopathy
Yoshihide Asano et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Endothelial-Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis
Naozumi Hashimoto et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study
V. Smith et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Cell Adhesion Molecules Regulate Fibrotic Process via Th1/Th2/Th17 Cell Balance in a Bleomycin-Induced Scleroderma Model
Ayumi Yoshizaki et al.
JOURNAL OF IMMUNOLOGY (2010)
Epithelial Cells Promote Fibroblast Activation via IL-1α in Systemic Sclerosis
Nima Aden et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Phenotype-Haplotype Correlation of IRF5 in Systemic Sclerosis: Role of 2 Haplotypes in Disease Severity
Philippe Dieude et al.
JOURNAL OF RHEUMATOLOGY (2010)
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
Timothy R. D. J. Radstake et al.
NATURE GENETICS (2010)
Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study
Dimitrios Daoussis et al.
RHEUMATOLOGY (2010)
Gastroesophageal Reflux Incites Interstitial Lung Disease in Systemic Sclerosis: Clinical, Radiologic, Histopathologic, and Treatment Evidence
Romy B. Christmann et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosis
Yukie Yamaguchi et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis
Nobuyo Higashi-Kuwata et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Digital Ischemia in Scleroderma Spectrum of Diseases
Elena Schiopu et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2010)
Digital Ischemic Loss in Systemic Sclerosis
Umaima Marvi et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2010)
Endothelial-Mesenchymal Transition as a Novel Mechanism for Generating Myofibroblasts during Diabetic Nephropathy
Akane Kizu et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Endothelial-Myofibroblast Transition Contributes to the Early Development of Diabetic Renal Interstitial Fibrosis in Streptozotocin-Induced Diabetic Mice
Jinhua Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Immunoglobulins from scleroderma patients inhibit the muscarinic receptor activation in internal anal sphincter smooth muscle cells
Jagmohan Singh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Gastroesophageal Reflux and Pulmonary Fibrosis in Scleroderma
Edoardo Savarino et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology or interferon induced?
T. Huegle et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients
A-L Hachulla et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility
Y. Kawaguchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Association Between the IRF5 rs2004640 Functional Polymorphism and Systemic Sclerosis
P. Dieude et al.
ARTHRITIS AND RHEUMATISM (2009)
Association of a Functional Polymorphism in the IRF5 Region With Systemic Sclerosis in a Japanese Population
Ikue Ito et al.
ARTHRITIS AND RHEUMATISM (2009)
Renal biopsy findings predicting outcome in scleroderma renal crisis
Ibrahim Batal et al.
HUMAN PATHOLOGY (2009)
Transcription Factor Fli1 Regulates Collagen Fibrillogenesis in Mouse Skin
Yoshihide Asano et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Centrilobular Fibrosis: An Underrecognized Pattern in Systemic Sclerosis
Romy B. C. de Souza et al.
RESPIRATION (2009)
Cardiac complications of systemic sclerosis
A. Kahan et al.
RHEUMATOLOGY (2009)
Renal complications and scleroderma renal crisis
C. P. Denton et al.
RHEUMATOLOGY (2009)
Induction of interferon-α by scleroderma sera containing autoantibodies to topoisomerase I
Daniel Kim et al.
ARTHRITIS AND RHEUMATISM (2008)
Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma
Hangjun Duan et al.
ARTHRITIS AND RHEUMATISM (2008)
Clinically significant interstitial lung disease in limited scleroderma - Histopathology, clinical features, and survival
Aryeh Fischer et al.
CHEST (2008)
Clinical association of serum interleukin-17 levels in systemic sclerosis: Is systemic sclerosis a Th17 disease?
Maki Murata et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2008)
Is scleroderma renal crisis with anti-centromere antibody-positive limited cutaneous systemic sclerosis overlooked in patients with hypertension and/or renal dysfunction?
Toshiro Sugimoto et al.
NEPHROLOGY (2008)
Myocardial involvement in systemic sclerosis
L. Belloli et al.
RHEUMATOLOGY (2008)
Outcome measures for heart involvement in systemic sclerosis
Y. Allanore et al.
RHEUMATOLOGY (2008)
Plasma D-dimer concentration in patients with systemic sclerosis
I. Marie et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Characterization of the innate immune response to chronic aspiration in a novel rodent model
James Z. Appel et al.
RESPIRATORY RESEARCH (2007)
Pattern and distribution of myocardial fibrosis in systemic sclerosis - A delayed enhanced magnetic resonance imaging study
George E. Tzelepis et al.
ARTHRITIS AND RHEUMATISM (2007)
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Elisabeth M. Zeisberg et al.
NATURE MEDICINE (2007)
Changes in causes of death in systemic sclerosis, 1972-2002
Virginia D. Steen et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Multiple sclerosis associated with systemic sclerosis
Syngliti-Henrietta Pelidou et al.
RHEUMATOLOGY INTERNATIONAL (2007)
Systemic sclerosis after interferon alphacon-1 therapy for hepatitis C
Hiroki Tahara et al.
INTERNAL MEDICINE (2007)
B cell infiltration in systemic sclerosis-associated interstitial lung disease
Robert Lafyatis et al.
ARTHRITIS AND RHEUMATISM (2007)
Interferon-α a prevents apoptosis of endothelial cells after short-term exposure but induces replicative senescence after continuous stimulation
Johannes Pammer et al.
LABORATORY INVESTIGATION (2006)
Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts
Youngqing Wang et al.
ARTHRITIS AND RHEUMATISM (2006)
Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis
Predrag Ostojic et al.
CLINICAL RHEUMATOLOGY (2006)
Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients
FK Tan et al.
RHEUMATOLOGY (2006)
Increased expression of integrin αvβ5 induces the myofibroblastic differentiation of dermal fibroblasts
Y Asano et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis
CA Davies et al.
HUMAN PATHOLOGY (2006)
Digital ulcers in patients with systemic sclerosis
L Chung et al.
AUTOIMMUNITY REVIEWS (2006)
Increased expression of integrin αvβ3 contributes to the establishment of autocrine TGF-β signaling in scleroderma fibroblasts
Y Asano et al.
JOURNAL OF IMMUNOLOGY (2005)
Autoantibodies in systemic sclerosis
VD Steen
SEMINARS IN ARTHRITIS AND RHEUMATISM (2005)
Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-β signaling in cultured scleroderma fibroblasts
Y Mimura et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Expression of Interleukin-21 Receptor in Epidermis From Patients With Systemic Sclerosis
Joerg H. W. Distler et al.
ARTHRITIS AND RHEUMATISM (2005)
Involvement of alpha V beta 5 integrin-mediated activation of latent transforming growth factor beta 1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts
Y Asano et al.
ARTHRITIS AND RHEUMATISM (2005)
Mortality in systemic sclerosis: an international meta-analysis of individual patient data
JPA Ioannidis et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Increased expression levels of integrin αvβ5 on scleroderma fibroblasts
Y Asano et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Defective vasculogenesis in systemic sclerosis
M Kuwana et al.
LANCET (2004)
Altered blood B lymphocyte Homeostasis in systemic sclerosis - Expanded naive B cells and diminished but activated memory B cells
S Sato et al.
ARTHRITIS AND RHEUMATISM (2004)
Systemic and cell type-specific gene expression patterns in scleroderma skin
ML Whitfield et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor α
C Chizzolini et al.
ARTHRITIS AND RHEUMATISM (2003)
Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies
C Feghali-Bostwick et al.
ARTHRITIS AND RHEUMATISM (2003)
Interstitial lung disease in scleroderma
B White
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2003)
Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement
V Steen et al.
ARTHRITIS AND RHEUMATISM (2003)
Predictors of end stage lung disease in a cohort of patients with scleroderma
C Morgan et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Plasma plasmin-α2-plasmin inhibitor complex levels are increased in systemic sclerosis patients with pulmonary hypertension
M Jinnin et al.
RHEUMATOLOGY (2003)
The prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis
Y Asano et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Importance of adipocytokines in obesity-related diseases
Y Matsuzawa et al.
HORMONE RESEARCH (2003)
Projection of an immunological self shadow within the thymus by the aire protein
MS Anderson et al.
SCIENCE (2002)
Esophageal striated muscle contractions in patients with gastroesophageal reflux symptoms
RO Dantas et al.
DIGESTIVE DISEASES AND SCIENCES (2002)
Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders
L Beretta et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome
D Bouros et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis
S Sato et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2001)
Quantitative genetic variation in CD19 expression correlates with autoimmunity
S Sato et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
